Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Post-Authorization Safety Studies of Medicinal Products
The PASS Book
An overview of findings from observational post-marketing studies that characterize the safety profile of pharmaceutical and biological products
Ayad K. Ali (Edited by), Abraham G. Hartzema (Edited by)
9780128092170, Elsevier Science
Hardback, published 19 June 2018
362 pages
23.4 x 19 x 2.5 cm, 0.91 kg
Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questions. Readers will be able to effectively and efficiently design and interpret findings from post-authorization safety studies with the goal of improving the benefit-risk balance of a drug in order to optimize patient safety.
1. Introduction 2. Risk Management Process 3. Data Sources for PASS 4. Study Designs for PASS 5. Analytical Approaches for PASS 6. Benefit-Risk Evaluation 7. Other PASS 8. EU PAS Register
Subject Areas: Pharmacology [MMG]
